125 related articles for article (PubMed ID: 3300950)
1. Serum ferritin in patients undergoing bone marrow transplantation.
Or R; Matzner Y; Konijn AM
Cancer; 1987 Sep; 60(5):1127-31. PubMed ID: 3300950
[TBL] [Abstract][Full Text] [Related]
2. Allogeneic bone marrow transplantation in the treatment of hematologic diseases.
Yee GC; McGuire TR
Clin Pharm; 1985; 4(2):149-60. PubMed ID: 3886273
[TBL] [Abstract][Full Text] [Related]
3. Glycosylated serum ferritin in patients with hematological malignancies before and after bone marrow transplantation.
Konijn AM; Kaplan R; Or R; Matzner Y
Leuk Lymphoma; 1992 May; 7(1-2):151-6. PubMed ID: 1472927
[TBL] [Abstract][Full Text] [Related]
4. [Allogenic bone marrow transplantation in the treatment of malignant hematologic disease].
Barriga F; Bertín P; Baeza R; Pereira J; Schwartzmann L; Oliva J; Ocqueteau M; Sapunar F; Duhalde M; Lira P
Rev Med Chil; 1995 May; 123(5):605-11. PubMed ID: 8525207
[TBL] [Abstract][Full Text] [Related]
5. [Innsbruck results of bone marrow transplantation in treatment of hematologic neoplasms and solid tumors].
Nachbaur D; Schwaighofer H; Thaler J; Weyrer W; Fink M; Nussbaumer W; Fritsch E; Niederwieser D
Wien Klin Wochenschr; 1994; 106(7):201-7. PubMed ID: 8197754
[TBL] [Abstract][Full Text] [Related]
6. Comparisons between allogeneic peripheral blood stem cell transplantation and allogeneic bone marrow transplantation in adult hematologic disease: a single center experience.
Liu YC; Chang CS; Liu TC; Chen TP; Sue YC; Hsiao HH; Lin SF
Kaohsiung J Med Sci; 2003 Nov; 19(11):541-8. PubMed ID: 14658482
[TBL] [Abstract][Full Text] [Related]
7. [Bone marrow transplantation in severe aplastic anemia and acute leukemia].
Speck B; Sartorius J; Cornu P; Nissen C; Weber W; Gratwohl A
Onkologie; 1979 Apr; 2(2):79-82. PubMed ID: 42865
[TBL] [Abstract][Full Text] [Related]
8. Monitoring of chimerism after allogeneic bone marrow transplantation with unmanipulated marrow by use of DNA polymorphisms.
Suttorp M; Schmitz N; Dreger P; Schaub J; Löffler H
Leukemia; 1993 May; 7(5):679-87. PubMed ID: 8097800
[TBL] [Abstract][Full Text] [Related]
9. [Indications, technique and risks in bone marrow transplantation in adulthood].
Heyll A; Söhngen D; Minning H; Meckenstock G; Aul C; Schneider W
Praxis (Bern 1994); 1996 Mar; 85(12):378-86. PubMed ID: 8643901
[TBL] [Abstract][Full Text] [Related]
10. [Treatment results of bone marrow transplantation in Kyushu Cancer Center. Bone Marrow Transplantation Team].
Tasaka H; Ikuno Y; Okamura J
Rinsho Ketsueki; 1990 Mar; 31(3):315-9. PubMed ID: 2366334
[TBL] [Abstract][Full Text] [Related]
11. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.
Slavin S; Naparstek E; Nagler A; Ackerstein A; Kapelushnik J; Or R
Exp Hematol; 1995 Dec; 23(14):1553-62. PubMed ID: 8542946
[TBL] [Abstract][Full Text] [Related]
12. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia.
Betticher DC; Huxol H; Müller R; Speck B; Nissen C
Exp Hematol; 1993 Nov; 21(12):1517-21. PubMed ID: 8405233
[TBL] [Abstract][Full Text] [Related]
13. New conditioning regimens for high risk marrow transplants.
Jones RJ; Santos GW
Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():15-7. PubMed ID: 2627618
[TBL] [Abstract][Full Text] [Related]
14. Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry.
Socié G; Stone JV; Wingard JR; Weisdorf D; Henslee-Downey PJ; Bredeson C; Cahn JY; Passweg JR; Rowlings PA; Schouten HC; Kolb HJ; Klein JP
N Engl J Med; 1999 Jul; 341(1):14-21. PubMed ID: 10387937
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic bone marrow transplantation for the patients with hemopoietic stem cell disorders: CUMC experience.
Kim DJ; Kim CC; Park CW; Han CH; Kim HK; Kim WI; Han KJ; Choi IB
Gan To Kagaku Ryoho; 1992 Jul; 19(8 Suppl):1188-92. PubMed ID: 1514832
[TBL] [Abstract][Full Text] [Related]
16. Cytogenetic studies in bone marrow transplant recipients.
Haas OA; Hinterberger W; Schmidmeier W; Pollak C; Hinterberger M; Gadner H; Lechner K
Blut; 1986 Jul; 53(1):29-38. PubMed ID: 3521766
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic bone marrow transplantation: experience with 92 patients.
Selby GB; Saez RA; Epstein RB; Slease RB; Confer DL
J Okla State Med Assoc; 1993 Dec; 86(12):599-603. PubMed ID: 8126587
[TBL] [Abstract][Full Text] [Related]
18. Analysis of 500 bone marrow transplants from unrelated donors (UR-BMT) facilitated by the Japan Marrow Donor Program: confirmation of UR-BMT as a standard therapy for patients with leukemia and aplastic anemia.
Kodera Y; Morishima Y; Kato S; Akiyama Y; Sao H; Matsuyama T; Kawa K; Sakamaki H; Nakagawa S; Hirabayashi N; Dohi H; Okamoto S; Hiraoka A; Gondo H; Tsuchida M; O H; Harada M; Asano S; Juji T; Sasazuki T; Takaku F
Bone Marrow Transplant; 1999 Nov; 24(9):995-1003. PubMed ID: 10556959
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow transplantation in Ramathibodi Hospital: progress report.
Jootar S; Chuncharunee S; Ungkanont A; Tanapothiwirut W; Chiewsilp P
Asian Pac J Allergy Immunol; 1992 Dec; 10(2):117-22. PubMed ID: 1305813
[TBL] [Abstract][Full Text] [Related]
20. Soluble interferon-gamma receptor and interferon-gamma in patients undergoing allogeneic bone marrow transplantation for hematological malignancies.
Toren A; Barak V; Novick D; Nagler A
Cytokines Cell Mol Ther; 1997 Sep; 3(3):153-8. PubMed ID: 9426973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
